Azithromycin Reduction to Reach Elimination of Trachoma B
The investigators propose a randomized controlled trial of discontinuation versus continuation of annual mass azithromycin distribution in hypoendemic communities of Maniema, DRC. The investigators will randomize communities with up to 20% Trachomatous Inflammation - Follicular (TF) prevalence following at least 5 years of mass azithromycin distribution to discontinuation or continuation of 3 additional years of annual mass azithromycin distribution.
- EligibilityCriteria: Inclusion Criteria:  Provision of appropriate informed consent Stated willingness to comply with all study procedures Live in one of the 80 communities with up to 20% prevalence of TF selected for the trial  Exclusion Criteria:  Does not consent to participation Unwilling to comply with all study procedures Does not live in one of the 80 communities with up to 20% prevalence of TF selected for the trial - HealthyVolunteers: Accepts Healthy Volunteers - Gender: All - MinimumAge: 1 Month - MaximumAge: 9 Years - StdAgeList: Child